Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives

Hepatocellular carcinoma: signaling pathways and therapeutic advances

Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

FDA's Approval of the First Biosimilar to Bevacizumab